1. 120. An open-label comparative trial of SUBA-itraconazole (SUBA) versus conventional itraconazole (c-itra) for treatment of proven and probable endemic mycoses (MSG-15): a pharmacokinetic (PK) and adverse Event (AE) analysis. (4th December 2021) Authors: Pappas, Peter G; Spec, Andrej; Miceli, Marisa; McGwin, Gerald; McMullen, Rachel; Thompson III, George R R Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗